Publishing and selling patents to large companies: does it fit the ‘commercial success’ criterion for EB-1?

Selling and licensing patents to large companies can indeed help demonstrate the commercial impact of your achievements under EB-1. When well documented, this activity shows that your work produced concrete results and earned market recognition, which speaks to both ‘commercial success’ and original contributions of significance.

The key is documentation. What gives this type of evidence its weight is the ability to show, clearly and verifiably, how the patents were adopted and what effect they had in your field.

• Licensing agreements and records that prove adoption of the patents.
• Evidence of technical impact or use by the companies involved.
• Publications, awards, or mentions that reinforce the recognition received.

Because no single piece of evidence decides the case on its own, it is evaluated as part of a broader body of proof. It is worth checking the current criteria with USCIS or a qualified specialist before filing.

About the author

Victoria Harper

Editor-in-Chief

Meet the author

As a journalist and lead editor at Visto n’ Visa, Victoria helps ensure that immigration topics are covered in a clear, trustworthy, and easy-to-understand way. Her focus is on delivering useful, human, and relevant content for people exploring new paths abroad.